Search Results

The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain

Authors: Sanderson, Lisa; Dogruel, Murat; Rodgers, Jean; Bradley, Barbara; Thomas, Sarah Ann

Source: Journal of Neurochemistry, Volume 107, Number 4, November 2008 , pp. 1136-1146(11)

Publisher: Blackwell Publishing

Medical treatment of hirsutism

Authors: Blume-Peytavi, Ulrike; Hahn, Susanne

Source: Dermatologic Therapy, Volume 21, Number 5, September/October 2008 , pp. 329-339(11)

Publisher: Blackwell Publishing

Eflornithine + sulindac reduces colorectal adenoma recurrence

Source: Inpharma, Volume 1, Number 1634, 2008-04-19 , pp. 11-11(1)

Publisher: Adis International

Say goodnight to African sleeping sickness with eflornithine

Source: Inpharma, Volume 1, Numbers 1630-1631, 2008-03-22 , pp. 13-13(1)

Publisher: Adis International

Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola

Authors: Robays, J.; Raguenaud, M. E.; Josenando, T.; Boelaert, M.

Source: Tropical Medicine & International Health, Volume 13, Number 2, February 2008 , pp. 265-271(7)

Publisher: Blackwell Publishing

Nifurtimox + eflornithine promising for trypanosomiasis

Source: Inpharma, Volume 1, Number 1616, 2007-12-01 , pp. 14-14(1)

Publisher: Adis International

The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism

Authors: Jackson, Joseph; Caro, J. Jaime; Caro, Graciela; Garfield, Frances; Huber, Ferdinand; Zhou, Wenjiong; Lin, Chen-Sheng; Shander, Douglas; Schrode, Kathy

Source: International Journal of Dermatology, Volume 46, Number 9, September 2007 , pp. 976-981(6)

Publisher: Blackwell Publishing

Dermatologic Manifestations of Polycystic Ovary Syndrome

Authors: Lee, Amy T.; Zane, Lee T.

Source: American Journal of Clinical Dermatology, Volume 8, Number 4, 2007 , pp. 201-219(19)

Publisher: Adis International

Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair

Authors: Wolf, John E.; Shander, Douglas; Huber, Ferdinand; Jackson, Joseph; Lin, Chen-Sheng; Mathes, Barbara M.; Schrode, Kathy

Source: International Journal of Dermatology, Volume 46, Number 1, January 2007 , pp. 94-98(5)

Publisher: Blackwell Publishing

New dimensions in Hirsutism

Authors: Randall, V.; Lanigan, S.; Hamzavi, I.; Chamberlain James, L.

Source: Lasers in Medical Science, Volume 21, Number 3, September 2006 , pp. 126-133(8)

Publisher: Springer

Eflornithine Cream Combined with Laser Therapy in the Management of Unwanted Facial Hair Growth in Women: A Randomized Trial

Authors: SMITH, STACY R.; PIACQUADIO, DANIEL J.; BEGER, BRIAN; LITTLER, CURT

Source: Dermatologic Surgery, Volume 32, Number 10, October 2006 , pp. 1237-1243(7)

Publisher: Blackwell Publishing

The elimination of Trypanosoma brucei gambiense sleeping sickness in the focus of Luba, Bioko Island, Equatorial Guinea

Authors: Simarro, P. P.; Franco, J. R.; Ndongo, P.; Nguema, E.; Louis, F. J.; Jannin, J.

Source: Tropical Medicine & International Health, Volume 11, Number 5, May 2006 , pp. 636-646(11)

Publisher: Blackwell Publishing

Eflornithine better tolerated than melarsoprol in trypanosomiasis

Source: Inpharma, Volume 1, Number 1513, 2005-11-12 , pp. 11-11(1)

Publisher: Adis International

Eflornithine better tolerated than melarsoprol in trypanosomiasis

Source: Reactions, Volume 1, Number 1078, 2005-11-19 , pp. 4-4(1)

Publisher: Adis International

New agents in intravesical chemotherapy of superficial bladder cancer

Authors: Perabo, Frank; Müller, Stefan

Source: Scandinavian Journal of Urology and Nephrology, Volume 39, Number 2, April 2005 , pp. 108-116(9)

Publisher: Informa Healthcare

Guidance for the management of hirsutism

Author: Dawber, Rodney P.R.

Source: Current Medical Research and Opinion, Volume 21, Number 8, August 2005 , pp. 1227-1234(8)

Publisher: Informa Healthcare

The pharmacokinetics of eflornithine (α-difluoromethylornithine) in patients with late-stage T.b. gambiense sleeping sickness

Authors: Na-Bangchang, K.; Doua, F.; Konsil, J.; Hanpitakpong, W.; Kamanikom, B.; Kuzoe, F.

Source: European Journal of Clinical Pharmacology, Volume 60, Number 4, June 2004 , pp. 269-278(10)

Publisher: Springer

Development of eflornithine [difluoromethylornithine, DFMO] has been discontinued

Source: Inpharma, Volume 1, Number 1424, 2004 , pp. 18-18(1)

Publisher: Adis International

High-performance liquid chromatographic method for determination of 2-difluoromethyl-dl-ornithine in plasma and cerebrospinal fluid

Authors: Hanpitakpong W.; Kamanikom B.; Banmairuroi V.; Na-Bangchang K.

Source: Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, Volume 788, Number 2, 25 May 2003 , pp. 221-231(11)

Publisher: Elsevier

The evaluation and management of hirsutism

Author: Azziz R.

Source: Obstetrics and Gynecology, Volume 101, Number 5, May 2003 , pp. 995-1007(13)

Publisher: Elsevier